Curia India is an API manufacturer based in India. It holds one active US drug master file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 16 February 2024 as VAI. Customs aggregates show $17.4M of exports covering 194 molecules to 21 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Aurangabad, India | 3008580576 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.1M | 6 |
| 2025 | Not reported | $17.4M | 21 |
| 2024 | Not reported | $14.9M | 27 |
| 2023 | Not reported | $18.5M | 18 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Curia India comes back tiered against every other supplier able to file there.
Start for free